乐心医疗
(300562)
| 流通市值：13.19亿 | | | 总市值：17.89亿 |
| 流通股本：1.60亿 | | | 总股本：2.17亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 884,256,692.63 | 608,042,980.31 | 384,642,662.72 | 162,605,363.38 |
| 营业收入 | 884,256,692.63 | 608,042,980.31 | 384,642,662.72 | 162,605,363.38 |
| 二、营业总成本 | 861,319,891.02 | 600,902,194.47 | 379,513,380.93 | 176,756,527.35 |
| 营业成本 | 610,688,155.12 | 422,156,088.76 | 275,648,843.19 | 118,943,301.84 |
| 税金及附加 | 7,612,364.86 | 5,733,356.9 | 4,214,872.85 | 2,156,513.37 |
| 销售费用 | 71,680,950.66 | 49,676,966.72 | 23,284,511.4 | 10,491,016.63 |
| 管理费用 | 72,729,528.04 | 57,259,747.57 | 39,253,262.12 | 15,128,508.52 |
| 研发费用 | 108,323,341.19 | 79,861,497.98 | 53,271,077.99 | 26,546,810.18 |
| 财务费用 | -9,714,448.85 | -13,785,463.46 | -16,159,186.62 | 3,490,376.81 |
| 其中:利息费用 | 4,276,132.38 | 3,404,731.16 | 2,091,527.71 | 1,080,641.63 |
| 其中:利息收入 | 7,417,374.7 | 6,320,821.89 | 5,149,418.77 | 2,694,692.32 |
| 加:公允价值变动收益 | 791,975.38 | -237,836.94 | -3,158,458.09 | -929,543.43 |
| 加:投资收益 | 2,530,133.18 | -66,917.67 | 901,323.27 | -320,195.51 |
| 资产处置收益 | -466,356.59 | 42,558.57 | 63,014.24 | -21,160.24 |
| 资产减值损失(新) | 3,476,987.08 | 6,631,961.67 | 6,536,323.52 | - |
| 信用减值损失(新) | -3,823,784.39 | -1,052,522.26 | -2,736,638.18 | 1,693,130.19 |
| 其他收益 | 9,080,006.87 | 4,311,653.79 | 2,579,171.43 | 1,513,026.74 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 34,525,763.14 | 16,769,683 | 9,314,017.98 | -12,215,906.22 |
| 加:营业外收入 | 86,449.58 | 58,514.65 | 3,319.53 | 20.02 |
| 减:营业外支出 | 1,501,151.39 | 207,723.07 | 183,622.15 | 37,358.57 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 33,111,061.33 | 16,620,474.58 | 9,133,715.36 | -12,253,244.77 |
| 减:所得税费用 | 1,913,819.3 | 1,501,984.21 | 733,316.17 | 81,276.31 |
| 六、净利润 | 31,197,242.03 | 15,118,490.37 | 8,400,399.19 | -12,334,521.08 |
| 持续经营净利润 | 31,197,242.03 | 15,118,490.37 | 8,400,399.19 | -12,334,521.08 |
| 归属于母公司股东的净利润 | 34,367,303.85 | 15,181,224.68 | 8,632,205.93 | -12,098,183.9 |
| 少数股东损益 | -3,170,061.82 | -62,734.31 | -231,806.74 | -236,337.18 |
| (一)基本每股收益 | 0.16 | 0.07 | 0.04 | -0.06 |
| (二)稀释每股收益 | 0.16 | 0.07 | 0.04 | -0.06 |
| 八、其他综合收益 | -7,088,587.72 | 662,583.15 | 806,030.25 | -301,379.44 |
| 归属于母公司股东的其他综合收益 | -7,088,587.72 | 662,583.15 | 806,030.25 | -301,379.44 |
| 九、综合收益总额 | 24,108,654.31 | 15,781,073.52 | 9,206,429.44 | -12,635,900.52 |
| 归属于母公司股东的综合收益总额 | 27,278,716.13 | 15,843,807.83 | 9,438,236.18 | -12,399,563.34 |
| 归属于少数股东的综合收益总额 | -3,170,061.82 | -62,734.31 | -231,806.74 | -236,337.18 |
| 公告日期 | 2024-03-26 | 2023-10-27 | 2023-08-15 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |